Business Description
The Hydration Pharmaceuticals Co Ltd
ISIN : AU0000187957
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -0.49 | |||||
Debt-to-Equity | -1.7 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -10.25 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.95 | |||||
9-Day RSI | 58.7 | |||||
14-Day RSI | 56.07 | |||||
6-1 Month Momentum % | 53.85 | |||||
12-1 Month Momentum % | -33.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.53 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 169.9 | |||||
Days Sales Outstanding | 48.07 | |||||
Days Payable | 153.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.02 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.24 | |||||
Operating Margin % | -68.6 | |||||
Net Margin % | -79.67 | |||||
FCF Margin % | -52.74 | |||||
ROE % | -446.6 | |||||
ROA % | -150.49 | |||||
ROIC % | -456.3 | |||||
ROC (Joel Greenblatt) % | -488.48 | |||||
ROCE % | -263.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.28 | |||||
EV-to-EBIT | -0.91 | |||||
EV-to-EBITDA | -0.91 | |||||
EV-to-Revenue | 0.63 | |||||
EV-to-FCF | -1.19 | |||||
Earnings Yield (Greenblatt) % | -109.89 | |||||
FCF Yield % | -146.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
The Hydration Pharmaceuticals Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 14.4 | ||
EPS (TTM) (A$) | -0.049 | ||
Beta | 0 | ||
Volatility % | 89.53 | ||
14-Day RSI | 56.07 | ||
14-Day ATR (A$) | 0.001216 | ||
20-Day SMA (A$) | 0.0162 | ||
12-1 Month Momentum % | -33.33 | ||
52-Week Range (A$) | 0.009 - 0.035 | ||
Shares Outstanding (Mil) | 304.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
The Hydration Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
The Hydration Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
The Hydration Pharmaceuticals Co Ltd Frequently Asked Questions
What is The Hydration Pharmaceuticals Co Ltd(ASX:HPC)'s stock price today?
When is next earnings date of The Hydration Pharmaceuticals Co Ltd(ASX:HPC)?
Does The Hydration Pharmaceuticals Co Ltd(ASX:HPC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |